Drug Discovery 2022: driving the next life science revolution

Prof Aravind Asokan

Prof Aravind Asokan
Prof Aravind Asokan
Duke University
Delegate / Speaker

Presentations at Drug Discovery 2022: driving the next life science revolution

Profile of Prof Aravind Asokan

Dr. Aravind Asokan is Professor and Director of Gene Therapy at Duke University in Durham, North Carolina, USA with appointments in the Departments of Surgery, Molecular Genetics and Microbiology as well as Biomedical Engineering. Originally trained as a pharmaceutical chemist, his lab blends the fields of protein & RNA engineering with molecular virology to enable transformative, new medicines. In particular, his lab is focused on developing innovative synthetic virology platforms based on Adeno-Associated Viruses (AAV) to enable gene therapy and gene editing. He is a founder and board director at StrideBio Inc., and TorqueBio, Inc. and serves as board director at the American Society of Gene and Cell Therapy (ASGCT) as well as on the advisory boards of Ring Therapeutics, Atsena Therapeutics, Kriya Therapeutics and Mammoth Bio.


Please login to send a Private Message

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'